Tandem t:slim X2 User Manual page 304

CHAPTER 32 • Overview of Control-IQ Technology Clinical Studies
The duration of infusion set used in both the DCLP3 and the DCLP5 was estimated by reviewing the number of times a t:slim X2
study pump was used to prime tubing. In the DCLP3 study, the average duration of infusion set use was 2.8 days in the SAP group
and 3.1 days in the Control-IQ technology group. In the DCLP5 study, the average duration of infusion set use was 2.6 days in the
SAP group and 2.8 days in the Control-IQ technology group.
DCLP3: Average Duration of Infusion Set Use (n=168)
Group
SAP
Control-IQ
DCLP5: Average Duration of Infusion Set Use (n=101)
Group
SAP
Control-IQ
302
N (pumps) Trial Days
12 2,412
122 20,412
N (pumps) Trial Days
11 1,128
90 15,159
Estimated Average
Primes Infusion Set Use
Duration
884 2.8 Days
7294 3.1 Days
Estimated Average
Primes Infusion Set Use
Duration
439 2.6 Days
5,379 2.8 Days